MedPath

Serratus Plane Block Versus Serratus Plane Block Plus Parasternal Block Combination for Breast Surgery

Not Applicable
Completed
Conditions
Analgesia
Cancer, Breast
Registration Number
NCT05911373
Lead Sponsor
Ataturk University
Brief Summary

Mastectomy is a technique often used in breast cancer surgery. Patients experience moderate to severe pain postoperatively after this procedure. Various plane blocks, NSAIDs, and opioid analgesics can be administered to these patients as components of multimodal analgesia. In the the study, the investigators aimed to evaluate the analgesic effects of the serratus plane block, the parasternal block added to the serratus plane block, and the dermatomal differences.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  1. American Society of Anesthesiologist's physiologic state I-III patients
  2. To undergo Mastectomy Surgery
  3. Being between the ages of 18-65 years
Exclusion Criteria
  • Having a known heart, kidney, liver or hematological disease
  • Having a history of peptic ulcer, gastrointestinal bleeding, allergy, chronic pain
  • Routine analgesic use and history of analgesic use in the last 24 hours
  • Not willing to participate in the study
  • Uncooperative patients who have coagulopathy or use anticoagulant drugs
  • To be allergic to one of the drugs to be used

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Postoperative opioid consumptionfirst 24 hours

First 24 hours total fentanyl consumption with patient controlled analgesia

Secondary Outcome Measures
NameTimeMethod
Sensory Assessment24 hours

Sensory Assessment will be performed on patients following the block procedure with pinprick test.

Visual analog pain scoreFirst 24 hours

Post operative pain will be evaluated with a Visual Analogue Scale (between 0-10; 0: no pain, 10:worst pain) score

Trial Locations

Locations (1)

Ali Ahiskalioglu

🇹🇷

Erzurum, Turkey

Ali Ahiskalioglu
🇹🇷Erzurum, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.